Corticosteroid therapy in nephrotic syndrome: A meta-analysis of randomised controlled trials

Archives of Disease in Childhood

Volumn 83, Issue 1, 2000, Pages 45-51

  Hodson, Elisabeth M ^a   Knight, John F ^a   Willis, Narelle S ^a   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Corticosteroid therapy; Meta analysis; Nephrotic syndrome; Systematic review

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; META ANALYSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; PREDNISONE; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TIME FACTORS;

EID: 0033913831     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.83.1.45     Document Type: Article

References (30)

1. 1 Anonymous. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981;98:561-4.
2. 2 Koskimies O, Vilska J, Rapola J, Hallman N. Long-term outcome of primary nephrotic syndrome. Arch Dis Child 1982;57:544-8.
3. 3 Arneil GC. The nephrotic syndrome. Pediatr Clin North Am 1971;18:547-59.
4. 4 Anonymous. Minimal change nephrotic syndrome in children: deaths during the first 5-15 years' observation. A report of the International Study of Kidney Disease in Children. Pediatrics 1984;73:497-501.
5. 5 Abramowicz M, Barnett HL, Edelmann CM Jr, et al. Controlled trial of azathioprine in children with nephrotic syndrome. Lancet 1970;1:959-561.
6. 6 Anonymous. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie". Lancet 1979;1:401-3.
7. 7 Brodehl J. The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 1991;150:380-7.
8. 8 Bargman JM. Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int Suppl 1999;70:S3-16.
9. 9 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
10. 10 Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium, Adelaide, Australia, 20-24 October 1996.
11. 11 Anonymous. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children. J Pediatr 1982;101:514-18.
12. 12 Crowther CA, Henderson-Smart DJ. Phenobarbital prior to preterm birth (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 1998.
13. 13 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
14. 14 Review Manager (RevMan) 3.1 for Windows. Oxford: The Cochrane Collaboration, 1998.
15. 15 Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-6.
16. 16 Anonymous. Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie". Eur J Pediatr 1981;135:229-37.
17. 17 Hiraoka M, Sudo M. Low versus standard dosage of prednisolone for initial treatment of idiopathic nephrotic syndrome in children. In: Proceedings of the American Society of Nephrology Conference, 3 November 1996.
18. 18 Kleinknecht C, Broyer M, Parchoux B, Loriat C, Nivet H, Palcoux JB, Ami-Moussa R. Comparison of short and long treatment at onset of steroid sensitive nephrosis (SSN). Preliminary results of a multicenter controlled trial from the French Society of Pediatric Nephrology. Int J Pediatr Nephrol 1982;3:45.
19. 19 Anonymous. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie". Lancet 1988;1:380-3.
20. 20 Ueda N, Chihara M, Kawaguchi S, et al. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 1988;112:122-6.
21. 21 Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie". Eur J Pediatr 1993;152:357-61.
22. 22 Ksiazek J, Wyszynski T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 1995;84:889-93.
23. 23 Norero C, Delucchi A, Lagos E, Rosati P. Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children. Rev Med Chil 1996;124:567-72.
24. 24 Bagga A, Hari P, Srivastava RN. Prolonged versus standard initial prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 1999;13:824-7.
25. 25 Anonymous. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children. J Pediatr 1979;95:239-43.
26. 26 Imbasciati E, Gusmano R, Edefonti A, et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. BMJ 1985;291:1305-8.
27. 27 Ekka BK, Bagga A, Srivastava RN. Single-versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 1997;11:597-9.
28. 28 Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol 1997;11:418-22.
29. 29 Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13.
30. 30 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34.